3 HATNUFA ST., YOKNEAM ILIT, L3
Other Events
Lifeward Ltd Completes Acquisition of Oratech Pharma
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reports Fourth Quarter and Full Year 2025 Financial Results Advancing Transformation into a Diversified Biomedical Innovation Company with a Clear Path to Cash Flow Positive
Shareholder Vote Results: Approval of Oratech Acquisition and Director Elections
Material disclosure
Director Departure - Hadar Levy Steps Down from Board of Lifeward Ltd
FY 2025
Q3
Q2
Q1
FY 2024
Notice of Exempt Offering of Securities
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities
S-1
Definitive Merger Proxy Statement
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
PREM14A
Correspondence
S-8 POS